Discriminative stimulus effects of panadiplon (U-78875), a partial agonist at the benzodiazepine site, in pentobarbital-trained rhesus monkeys

被引:3
|
作者
Rowlett, JK [1 ]
Woolverton, WL [1 ]
机构
[1] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA
关键词
benzodiazepine; barbiturates; pentobarbital; drug discrimination; panadiplon; (U-78875; PNU-78875); abuse potential;
D O I
10.1016/S0376-8716(00)00142-3
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The pentobarbital-like discriminative stimulus effects of the benzodiazepine receptor partial agonist panadiplon were assessed in rhesus monkeys trained to discriminate pentobarbital (10 mg/kg) from saline. In test sessions, pentobarbital and the benzodiazepine full agonist triazolam engendered near 100% drug-appropriate responding in all monkeys, whereas panadiplon engendered near 100% drug-appropriate responding in two of four monkeys. Panadiplon pretreatment resulted in leftward shifts in the pentobarbital dose-response function but predominantly rightward shifts of the triazolam dose-response function. These results are consistent with findings that benzodiazepine partial agonists have pentobarbital-like discriminative stimulus effects in some subjects only, and further suggest that partial agonists enhance the effects of pentobarbital but antagonize the effects of a benzodiazepine full agonist. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:229 / 236
页数:8
相关论文
共 26 条
  • [11] Discriminative stimulus effects of benzodiazepine (BZ)1 receptor-selective ligands in rhesus monkeys
    McMahon, LR
    Gerak, LR
    Carter, L
    Ma, CR
    Cook, JM
    France, CP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (02): : 505 - 512
  • [12] The cannabinoid agonist HU-210: Pseudo-irreversible discriminative stimulus effects in rhesus monkeys
    Hruba, Lenka
    McMahon, Lance R.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 727 : 35 - 42
  • [13] Nicotine-like discriminative stimulus effects of acetylcholinesterase inhibitors and a muscarinic receptor agonist in Rhesus monkeys
    Moerke, Megan J.
    McMahon, Lance R.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2019, 45 (05) : 861 - 867
  • [14] Characterization of the Discriminative Stimulus Effects of a NOP Receptor Agonist Ro 64-6198 in Rhesus Monkeys
    Saccone, Phillip A.
    Zelenock, Kathy A.
    Lindsey, Angela M.
    Sulima, Agnieszka
    Rice, Kenner C.
    Prinssen, Eric P.
    Wichmann, Juergen
    Woods, James H.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 357 (01): : 17 - 23
  • [15] Behavioral effects of flunitrazepam: reinforcing and discriminative stimulus effects in rhesus monkeys and prevention of withdrawal signs in pentobarbital-dependent rats
    Gerak, LR
    Woolverton, WL
    Nader, MA
    Patrick, GA
    Harris, LS
    Winger, G
    Woods, JH
    France, CP
    DRUG AND ALCOHOL DEPENDENCE, 2001, 63 (01) : 39 - 49
  • [16] Attenuation of the discriminative stimulus effects of ethanol by the benzodiazepine partial inverse agonist Ro 15-4513
    Gatto, GJ
    Grant, KA
    BEHAVIOURAL PHARMACOLOGY, 1997, 8 (2-3): : 139 - 146
  • [17] Discriminative stimulus effects of GABAA/benzodiazepine (BZ) modulators in rhesus monkeys:: Studies with the BZ-1 antagonist β-CCt
    McMahon, LR
    Carter, L
    Gerak, LR
    France, CP
    FASEB JOURNAL, 2001, 15 (05): : A912 - A912
  • [18] Discriminative stimulus effects of zolpidem in pentobarbibtal-trained subjects .1. Comparison with triazolam in rhesus monkeys and rats
    Rowlett, JK
    Woolverton, WL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 280 (01): : 162 - 173
  • [19] Daily Synthetic Cannabinoid Agonist (JWH-018) Treatment: Tolerance to Δ9-Tetrahydrocannabinol-Like Discriminative Stimulus Effects in Rhesus Monkeys
    Cocke, Morgan L.
    McMahon, Lance R.
    FASEB JOURNAL, 2016, 30
  • [20] The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys
    Cindy Achat-Mendes
    Donna M. Platt
    Amy H. Newman
    Roger D. Spealman
    Psychopharmacology, 2009, 206 : 73 - 84